Potent inhibitors of the HIV-1 protease incorporating cyclic urea P1–P2 scaffold
- 15 September 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (22) , 5685-5687
- https://doi.org/10.1016/j.bmcl.2004.08.038
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Discovery of potent pyrrolidone-based HIV-1 protease inhibitors with enhanced drug-like propertiesBioorganic & Medicinal Chemistry Letters, 2004
- Novel prodrug approach to amprenavir-based HIV-1 protease inhibitors via O→N acyloxy migration of P1 moietyBioorganic & Medicinal Chemistry Letters, 2003
- Novel spirocyclic pyrrolidones as P2/P1 mimetics in potent inhibitors of HIV-1 proteaseBioorganic & Medicinal Chemistry Letters, 2002
- Novel inhibitors of HIV proteaseBioorganic & Medicinal Chemistry Letters, 2000
- Novel and Efficient Synthesis of Spirocyclic Morpholinones as Precursors of ψ[CH2O] Dipeptide IsosteresSynthesis, 1999
- Design and synthesis of novel conformationally restricted HIV protease inhibitorsBioorganic & Medicinal Chemistry Letters, 1998
- Highly diastereoselective reaction of a chiral, non-racemic amide enolate with (S)-glycidyl tosylate. Synthesis of the orally active HIV-1 protease inhibitor L-735,524Tetrahedron Letters, 1994